{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:14:34Z","timestamp":1779898474075,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thyroid Res"],"DOI":"10.1186\/s13044-025-00236-9","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T22:03:14Z","timestamp":1745445794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Are liquid levothyroxine formulations comparable? The LETI study"],"prefix":"10.1186","volume":"18","author":[{"given":"Elisa","family":"Gatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Maltese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pirola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gandossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Silvestrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Ugoccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Casella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"10101","key":"236_CR1","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/s0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(17)30703-1.","journal-title":"Lancet"},{"issue":"6","key":"236_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","volume":"7","author":"WM Tunbridge","year":"1977","unstructured":"Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7(6):481\u201393. https:\/\/doi.org\/10.1111\/j.1365-2265.1977.tb01340.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"236_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55\u201368. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb01894.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"236_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489\u201399. https:\/\/doi.org\/10.1210\/jcem.87.2.8182.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"236_CR5","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670\u2013751. https:\/\/doi.org\/10.1089\/thy.2014.0028.","journal-title":"Thyroid"},{"key":"236_CR6","doi-asserted-by":"publisher","first-page":"1334292","DOI":"10.3389\/fendo.2023.1334292","volume":"14","author":"C Cappelli","year":"2023","unstructured":"Cappelli C, Gatta E, Ippolito S. Levothyroxine personalized treatment: is it still a dream? Front Endocrinol (Lausanne). 2023;14:1334292. https:\/\/doi.org\/10.3389\/fendo.2023.1334292.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"236_CR7","doi-asserted-by":"publisher","first-page":"15e","DOI":"10.1701\/3827.38159","volume":"113","author":"C Virili","year":"2022","unstructured":"Virili C. The malabsorption of levothyroxine: a kaleidoscope of comorbidities? Recenti Prog Med. 2022;113(6):15e-e18. https:\/\/doi.org\/10.1701\/3827.38159.","journal-title":"Recenti Prog Med"},{"issue":"3","key":"236_CR8","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1208\/s12249-010-9515-8","volume":"11","author":"RB Shah","year":"2010","unstructured":"Shah RB, Collier JS, Sayeed VA, Bryant A, Habib MJ, Khan MA. Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium. AAPS PharmSciTech. 2010;11(3):1359\u201367. https:\/\/doi.org\/10.1208\/s12249-010-9515-8.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"236_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1530\/eje-15-0314","volume":"173","author":"SC Del Duca","year":"2015","unstructured":"Del Duca SC, Santaguida MG, Brusca N, Gatto I, Cellini M, Gargano L, et al. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study. Eur J Endocrinol. 2015;173(3):351\u20137. https:\/\/doi.org\/10.1530\/eje-15-0314.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"236_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1089\/thy.2012.0435","volume":"23","author":"CL Perez","year":"2013","unstructured":"Perez CL, Araki FS, Graf H, de Carvalho GA. Serum thyrotropin levels following levothyroxine administration at breakfast. Thyroid. 2013;23(7):779\u201384. https:\/\/doi.org\/10.1089\/thy.2012.0435.","journal-title":"Thyroid"},{"issue":"6","key":"236_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.eurger.2014.09.006","volume":"5","author":"C Cappelli","year":"2014","unstructured":"Cappelli C, Pirola I, Daffini L, Gandossi E, Agosti B, Castellano M. Thyroid hormonal profile in elderly patients treated with two different levothyroxine formulations: A single institute survey. European Geriatric Medicine. 2014;5(6):382\u20135. https:\/\/doi.org\/10.1016\/j.eurger.2014.09.006.","journal-title":"European Geriatric Medicine"},{"key":"236_CR12","doi-asserted-by":"publisher","first-page":"7053959","DOI":"10.1155\/2017\/7053959","volume":"2017","author":"C Cappelli","year":"2017","unstructured":"Cappelli C, Pirola I, Gandossi E, Casella C, Lombardi D, Agosti B, et al. TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form. Int J Endocrinol. 2017;2017:7053959. https:\/\/doi.org\/10.1155\/2017\/7053959.","journal-title":"Int J Endocrinol"},{"key":"236_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2018.00010","volume":"9","author":"C Virili","year":"2018","unstructured":"Virili C, Giovanella L, Fallahi P, Antonelli A, Santaguida MG, Centanni M, et al. Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2018;9:10. https:\/\/doi.org\/10.3389\/fendo.2018.00010.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"236_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.2015.0422","volume":"26","author":"C Cappelli","year":"2016","unstructured":"Cappelli C, Pirola I, Daffini L, Formenti A, Iacobello C, Cristiano A, et al. A Double-Blind Placebo-Controlled Trial of Liquid Thyroxine Ingested at Breakfast: Results of the TICO Study. Thyroid. 2016;26(2):197\u2013202. https:\/\/doi.org\/10.1089\/thy.2015.0422.","journal-title":"Thyroid"},{"key":"236_CR15","doi-asserted-by":"publisher","first-page":"1080108","DOI":"10.3389\/fendo.2022.1080108","volume":"13","author":"E Gatta","year":"2022","unstructured":"Gatta E, Bambini F, Buoso C, Gava M, Maltese V, Anelli V, et al. Liquid levothyroxine formulations in patients taking drugs interfering with L-T4 absorption. Front Endocrinol (Lausanne). 2022;13:1080108. https:\/\/doi.org\/10.3389\/fendo.2022.1080108.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"236_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s11695-013-1015-y","volume":"23","author":"I Pirola","year":"2013","unstructured":"Pirola I, Formenti AM, Gandossi E, Mittempergher F, Casella C, Agosti B, et al. Oral liquid L-thyroxine (L-t4) may be better absorbed compared to L-T4 tablets following bariatric surgery. Obes Surg. 2013;23(9):1493\u20136. https:\/\/doi.org\/10.1007\/s11695-013-1015-y.","journal-title":"Obes Surg"},{"issue":"6","key":"236_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40618-014-0082-9","volume":"37","author":"I Pirola","year":"2014","unstructured":"Pirola I, Daffini L, Gandossi E, Lombardi D, Formenti A, Castellano M, et al. Comparison between liquid and tablet levothyroxine formulations in patients treated through enteral feeding tube. J Endocrinol Invest. 2014;37(6):583\u20137. https:\/\/doi.org\/10.1007\/s40618-014-0082-9.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"236_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1871530318666180125155348","volume":"18","author":"R Guglielmi","year":"2018","unstructured":"Guglielmi R, Grimaldi F, Negro R, Frasoldati A, Misischi I, Graziano F, et al. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients. Endocr Metab Immune Disord Drug Targets. 2018;18(3):235\u201340. https:\/\/doi.org\/10.2174\/1871530318666180125155348.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"12","key":"236_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1055\/s-0032-1329951","volume":"62","author":"CS Yue","year":"2012","unstructured":"Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012;62(12):631\u20136. https:\/\/doi.org\/10.1055\/s-0032-1329951.","journal-title":"Arzneimittelforschung."},{"key":"236_CR20","doi-asserted-by":"publisher","first-page":"633587","DOI":"10.3389\/fendo.2021.633587","volume":"12","author":"A Antonelli","year":"2021","unstructured":"Antonelli A, Elia G, Ragusa F, Paparo SR, Cavallini G, Benvenga S, et al. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine. Front Endocrinol (Lausanne). 2021;12:633587.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"236_CR21","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.beem.2009.06.006","volume":"23","author":"L Liwanpo","year":"2009","unstructured":"Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781\u201392. https:\/\/doi.org\/10.1016\/j.beem.2009.06.006.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"236_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1471-2458-9-132","volume":"9","author":"AL Mitchell","year":"2009","unstructured":"Mitchell AL, Hickey B, Hickey JL, Pearce SH. Trends in thyroid hormone prescribing and consumption in the UK. BMC Public Health. 2009;9:132. https:\/\/doi.org\/10.1186\/1471-2458-9-132.","journal-title":"BMC Public Health"},{"issue":"368","key":"236_CR23","first-page":"107","volume":"43","author":"J Parle","year":"1993","unstructured":"Parle J, Franklyn J, Cross K, Jones S, Sheppard M. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract. 1993;43(368):107\u20139.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"236_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/thy.1995.5.249","volume":"5","author":"S Benvenga","year":"1995","unstructured":"Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F. Delayed intestinal absorption of levothyroxine. Thyroid. 1995;5(4):249\u201353. https:\/\/doi.org\/10.1089\/thy.1995.5.249.","journal-title":"Thyroid"},{"key":"236_CR25","doi-asserted-by":"publisher","first-page":"1386629","DOI":"10.3389\/fendo.2024.1386629","volume":"15","author":"P Fallahi","year":"2024","unstructured":"Fallahi P, Ragusa F, Patrizio A, Mazzi V, Botrini C, Elia G, et al. Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational study. Front Endocrinol (Lausanne). 2024;15:1386629. https:\/\/doi.org\/10.3389\/fendo.2024.1386629.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"236_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.eprac.2024.03.005","volume":"30","author":"BB Henderson","year":"2024","unstructured":"Henderson BB, Smith SP, Mengelkamp ME, Rhymer EK, Gray KN, Jackson AG, et al. Liquid Thyroxine Improves Outcomes in Hypothyroid Patients With Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome. Endocr Pract. 2024;30(6):505\u201312. https:\/\/doi.org\/10.1016\/j.eprac.2024.03.005.","journal-title":"Endocr Pract"},{"key":"236_CR27","doi-asserted-by":"publisher","unstructured":"Bocale R, Desideri G, Barini A, D'Amore A, Boscherini M, Necozione S, et al. Long-Term Adherence to Levothyroxine Replacement Therapy in Thyroidectomized Patients. J Clin Med. 2022;11(15).\u00a0https:\/\/doi.org\/10.3390\/jcm11154296.","DOI":"10.3390\/jcm11154296"},{"issue":"5","key":"236_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5603\/EP.a2020.0065","volume":"71","author":"M Gietka-Czernel","year":"2020","unstructured":"Gietka-Czernel M, Hubalewska-Dydejczyk A, Kos-Kud\u0142a B, Lewi\u0144ski A, Rucha\u0142a M, Syrenicz A, et al. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspert\u00f3w dotycz\u0105ca stosowania p\u0142ynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynno\u015b\u0107 tarczycy]. Endokrynol Pol. 2020;71(5):441\u201365. https:\/\/doi.org\/10.5603\/EP.a2020.0065.","journal-title":"Endokrynol Pol"},{"key":"236_CR29","doi-asserted-by":"publisher","unstructured":"Bornikowska K, Gietka-Czernel M, Raczkiewicz D, Glinicki P, Zgliczy\u0144ski W. Improvements in Quality of Life and Thyroid Parameters in Hypothyroid Patients on Ethanol-Free Formula of Liquid Levothyroxine Therapy in Comparison to Tablet LT4 Form: An Observational Study. J Clin Med. 2021;10(22).\u00a0https:\/\/doi.org\/10.3390\/jcm10225233.","DOI":"10.3390\/jcm10225233"},{"issue":"1","key":"236_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000508216","volume":"10","author":"GK Markantes","year":"2021","unstructured":"Markantes GK, Dimitropoulos K, Mamali I, Tseti I, Sakellaropoulos G, Markou KB, et al. Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism. Eur Thyroid J. 2021;10(1):59\u201364. https:\/\/doi.org\/10.1159\/000508216.","journal-title":"Eur Thyroid J"},{"key":"236_CR31","doi-asserted-by":"publisher","first-page":"123893","DOI":"10.1016\/j.ijpharm.2024.123893","volume":"653","author":"N Fine-Shamir","year":"2024","unstructured":"Fine-Shamir N, Dahan A. Ethanol-based solubility-enabling oral drug formulation development: Accounting for the solubility-permeability interplay. Int J Pharm. 2024;653:123893.","journal-title":"Int J Pharm"},{"issue":"11","key":"236_CR32","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s40618-018-0867-3","volume":"41","author":"I Pirola","year":"2018","unstructured":"Pirola I, Gandossi E, Brancato D, Marini F, Cristiano A, Delbarba A, et al. TSH evaluation in hypothyroid patients assuming liquid levothyroxine at breakfast or 30 min before breakfast. J Endocrinol Invest. 2018;41(11):1301\u20136. https:\/\/doi.org\/10.1007\/s40618-018-0867-3.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"236_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/09513590.2015.1113518","volume":"32","author":"C Cappelli","year":"2016","unstructured":"Cappelli C, Negro R, Pirola I, Gandossi E, Agosti B, Castellano M. Levothyroxine liquid solution versus tablet form for replacement treatment in pregnant women. Gynecol Endocrinol. 2016;32(4):290\u20132. https:\/\/doi.org\/10.3109\/09513590.2015.1113518.","journal-title":"Gynecol Endocrinol"}],"container-title":["Thyroid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13044-025-00236-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13044-025-00236-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T22:03:15Z","timestamp":1745445795000},"score":1,"resource":{"primary":{"URL":"https:\/\/thyroidresearchjournal.biomedcentral.com\/articles\/10.1186\/s13044-025-00236-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1186\/s13044-025-00236-9","relation":{},"ISSN":["1756-6614"],"issn-type":[{"value":"1756-6614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}